Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Aurobindo Pharma Ltd.
NSE: AUROPHARMA
|
BSE: 524804
|
ISIN: INE406A01037
|
Industry: Pharmaceuticals
|
Mid-range Performer
1096.3000
-13.60
(
-1.23
%)
NSE
Sep 24, 2025
10:49 AM
28.41% Fall from 52W High
Volume:
337.0K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Aurobindo Pharma Ltd.
04 Jun 2020
1096.30
-1.23%
Aurobindo Pharma (BUY): Strong Q4; upside risk to EPS can support higher multiple
Buy:
Aurobindo Pharma Ltd.
by
BOB Capital Markets Ltd.
Target: 900
Target
BOB Capital Markets Ltd.
Revenue/EBITDA beat estimates by 2%/9% led by strong sales (ex-US) and gross margin expansion.
Aurobindo Pharma Ltd. has lost
-25.97%
in the last 1 Year
More from Aurobindo Pharma Ltd.
Recommended
Market trades lower, Swiggy approves Instamart sale to arm Scootsy Logistics
Trendlyne Marketwatch |
24 Sep 2025, 10:43AM
Five stocks to buy from analysts this week - September 23, 2025
The Baseline |
23 Sep 2025, 06:11PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
|
15 Jul 2020